Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?

Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?

Rheumatoid arthritis is an autoimmune systemic disease characterized mainly by inflammatory compromise of diarthrodial joints. Multiple drug therapies have been developed to control the activity of rheumatoid arthritis, among them, the first line of disease-modifying antirheumatic drugs (DMARD), and...

Full description

Bibliographic Details
Main Authors:	John-Leonardo Torres-Castiblanco, Jorge Alberto Carrillo, Daniel Hincapié-Urrego, Adriana Rojas-Villarraga
Format:	Article
Language:	English
Published:	Instituto Nacional de Salud 2018-03-01
Series:	Biomédica: revista del Instituto Nacional de Salud
Subjects:	Mycobacterium tuberculosis tuberculosis diagnosis arthritis, rheumatoid risk factor tumor necrosis factor-alpha biological therapy infliximab Colombia
Online Access:	https://www.revistabiomedica.org/index.php/biomedica/article/view/3458

Similar Items

Tuberculosis associated with tumor necrosis factor-α antagonists, case description and analysis of reported cases in Colombia
by: Leandro Galvis, et al.
Published: (2018-03-01)

Treatment of rheumatoid arthritis patients – a challenge
by: Luiza Maria Pana, et al.
Published: (2020-09-01)

Tuberculosis en pacientes tratados con antagonistas del factor de necrosis tumoral alfa en un área endémica, ¿vale la pena el riesgo?
by: Adriana Rojas-Villarraga, et al.
Published: (2007-06-01)

Polimorfismo del TNF-alpha en autoinmunidad y tuberculosis.
by: Paula A. Correa, et al.
Published: (2004-06-01)

Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
by: Mehmet Unlu, et al.
Published: (2014-01-01)

Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy
by: Tae Sun Shim
Published: (2014-01-01)

Incidencia de tuberculosis en pacientes que reciben fármacos anti-TNFα
by: Ana Gruss, et al.
Published: (2020-03-01)

Relationship between beliefs about medicines, adherence to treatment, and disease activity in patients with rheumatoid arthritis under subcutaneous anti-TNFα therapy
by: Horne R, et al.
Published: (2018-06-01)

Inhibition of TNF-α Restores Muscle Force, Inhibits Inflammation, and Reduces Apoptosis of Traumatized Skeletal Muscles
by: Ioannis Stratos, et al.
Published: (2022-08-01)

Latent tuberculosis infection in patients with rheumatic diseases
by: Camila Anton, et al.
Published: (2019-04-01)

Correlation of melatonin and TNF-α levels with characteristics of sleep in patients with rheumatoid arthritis
by: Yu. K. Sikalo, et al.
Published: (2015-02-01)

Latent Tuberculosis Infection and Tuberculosis Development in Children Treated with Anti-TNF-α Agents
by: Aykut EŞKİ, et al.
Published: (2023-07-01)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
by: E. A. Golikova, et al.
Published: (2012-05-01)

Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area
by: Andrea Yukie Shimabuco, et al.
Published: (2020-11-01)

Analysis of the results of the mantoux test with 2 TE in children with rheumatoid arthritis when prescribing genetically engineered drugs
by: M. V. Uraksina, et al.
Published: (2023-03-01)

Mycobacterium Marinum Infection after Infliximab Therapy
by: Safaa Alkhawaja, et al.
Published: (2010-12-01)

Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis
by: Motoi Uchino, et al.
Published: (2017-10-01)

How to Treat Patients after Serious Adverse Effects Caused by TNF Inhibitors?
by: Saša Sršen, et al.
Published: (2020-01-01)

Perfil de utilización de los anti-factor de necrosis tumoral en pacientes de Colombia
by: Jorge Machado, et al.
Published: (2011-03-01)

Anti-TNF treatment and miliary tuberculosis in Crohn’s disease
by: Milenković Branislava, et al.
Published: (2011-01-01)

Correlation between carotid intima-media thickness and serum TNF-alpha levels in female with rheumatoid arthritis of different ethnicities: A single-centre experience in Malaysia
by: Kek Xin Yi, et al.
Published: (2019-12-01)

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease
by: J Dretzke, et al.
Published: (2011-02-01)

Comparative Analysis of TNF-alpha, TNF-R1, and TNF-R2 in Patients with Low-impact Fractures Due to Osteoporosis
by: Abel Oliveira Marques Teixeira, et al.
Published: (2023-07-01)

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
by: Castagna Irene, et al.
Published: (2003-08-01)

Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review
by: Jae Hoon Jung, et al.
Published: (2022-02-01)

Anti-Tumor Necrosis Factor-alpha in therapy of severe alcoholic hepatitis: a case report
by: M. Romano, et al.
Published: (2013-05-01)

Pregnancy Outcumes and Contraceptive Use in Women with Rheumatoid Arthritis: A Comparative Study
by: Lobaba Basim Mohammed Salih, et al.
Published: (2022-12-01)

IL-17 Production of Neutrophils Enhances Antibacteria Ability but Promotes Arthritis Development During Mycobacterium tuberculosis Infection
by: Shengfeng Hu, et al.
Published: (2017-09-01)

Tuberculosis the great masquerader
by: Elizabeth Wenqian Wang, et al.
Published: (2022-01-01)

Anti-TNFα therapy in the management of psoriasis: experience of a state referral center
by: Laura Maria Andrade Silva, et al.
Published: (2014-06-01)

Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis
by: Anna Szeremeta, et al.
Published: (2018-09-01)

TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients
by: Calvo Alén J, et al.
Published: (2022-10-01)

A major pain in the hip - Destruction of the left acetabulum and femoral head secondary to Tuberculosis: A case report and review of the literature
by: Dominic A. Haigh, et al.
Published: (2024-03-01)

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials
by: Tsutomu Takeuchi, et al.
Published: (2023-04-01)

Comparison of serum tumor necrosis factor-α levels in rheumatoid arthritis individuals with and without chronic periodontitis: A biochemical study
by: Sivasankari Thilagar, et al.
Published: (2018-01-01)

Tuberculosis en Colombia: análisis de la situación epidemiológica, año 2006 Epidemiologic situation of tuberculosis in Colombia, 2006
by: César Augusto Castiblanco, et al.
Published: (2008-09-01)

Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking
by: Liang Liang Bai, et al.
Published: (2021-05-01)

GOUT – induced by Infliximab?- case report
by: Anca Chiriac, et al.
Published: (2012-10-01)

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01)

Contribución del análisis RFLP del IS6110 de Mycobacterium tuberculosis al diseño y refinamiento de estrategias para el control de la tuberculosis en Colombia Contribution of M. tuberculosis IS6110 based RFLP assay to the design and refinement of tuberculosis control strategies in Colombia
by: Doris Amanda Rosero, et al.
Published: (2008-09-01)